Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Anavex Life Sciences stock
Learn how to easily invest in Anavex Life Sciences stock.
Anavex Life Sciences Corp is a biotechnology business based in the US. Anavex Life Sciences shares (AVXL) are listed on the NASDAQ and all prices are listed in US Dollars. Anavex Life Sciences employs 25 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Anavex Life Sciences
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – AVXL – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Anavex Life Sciences stock price (NASDAQ: AVXL)Use our graph to track the performance of AVXL stocks over time.
Anavex Life Sciences shares at a glance
|Latest market close||$13.22|
|52-week range||$5.56 - $31.50|
|50-day moving average||$18.71|
|200-day moving average||$17.81|
|Wall St. target price||$38.29|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.54|
Buy Anavex Life Sciences shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Anavex Life Sciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Anavex Life Sciences price performance over time
|1 week (2022-01-12)||-10.01%|
|1 month (2021-12-16)||-26.23%|
|3 months (2021-10-15)||N/A|
|6 months (2021-07-19)||-38.65%|
|1 year (2021-01-19)||121.07%|
|2 years (2020-01-17)||300.61%|
|3 years (2019-01-18)||626.37%|
|5 years (2017-01-19)||214.76%|
Anavex Life Sciences financials
|Gross profit TTM||$0|
|Return on assets TTM||-23.87%|
|Return on equity TTM||-42.58%|
|Market capitalisation||$1.1 billion|
TTM: trailing 12 months
Anavex Life Sciences share dividends
We're not expecting Anavex Life Sciences to pay a dividend over the next 12 months.
Have Anavex Life Sciences's shares ever split?
Anavex Life Sciences's shares were split on a 1:4 basis on 6 October 2015. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Anavex Life Sciences shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Anavex Life Sciences shares which in turn could have impacted Anavex Life Sciences's share price.
Anavex Life Sciences share price volatility
Over the last 12 months, Anavex Life Sciences's shares have ranged in value from as little as $5.56 up to $31.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Anavex Life Sciences's is 0.5651. This would suggest that Anavex Life Sciences's shares are less volatile than average (for this exchange).
Anavex Life Sciences overview
Anavex Life Sciences Corp. , a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinical clinical trials to treat epilepsy, infantile spasms, Fragile X syndrome, Angelman syndrome, multiple sclerosis, and tuberous sclerosis complex. The company's drug candidate also comprises ANAVEX 3-71, which is in Phase I clinical trial for the treatment of frontotemporal dementia and other dementia indications; and preclinical clinical trials for the treatment of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases. Its preclinical drug candidates include ANAVEX 1-41, a sigma-1 receptor agonist for the treatment of depression, stroke, Parkinson's, and Alzheimer's diseases; ANAVEX 1066, a mixed sigma-1/sigma-2 ligand for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. The company was incorporated in 2004 and is headquartered in New York, New York. .
Anavex Life Sciences in the news
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Anavex: 2022 Has Major, Pivotal Catalysts
Noteworthy Friday Option Activity: TTD, AVXL, PACK
Frequently asked questionsWhat percentage of Anavex Life Sciences is owned by insiders or institutions?
Currently 3.204% of Anavex Life Sciences shares are held by insiders and 28.142% by institutions. How many people work for Anavex Life Sciences?
Latest data suggests 25 work at Anavex Life Sciences. When does the fiscal year end for Anavex Life Sciences?
Anavex Life Sciences's fiscal year ends in September. Where is Anavex Life Sciences based?
Anavex Life Sciences's address is: 51 West 52nd Street, New York, NY, United States, 10019 What is Anavex Life Sciences's ISIN number?
Anavex Life Sciences's international securities identification number is: US0327973006 What is Anavex Life Sciences's CUSIP number?
Anavex Life Sciences's Committee on Uniform Securities Identification Procedures number is: 032797102
More guides on Finder
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
Can Turo’s IPO do better than Uber and Airbnb?
Car-sharing service Turo has filed plans for an IPO. What you need to know.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
How to buy VinFast stock when it goes public
Everything we know about the VinFast IPO, plus information on how to buy in.
NFT-funded LinksDAO moves $10.5 million closer to buying a golf course
Creating a golf club is a thus-far unique application of NFTs, and another step forward for the decentralized economy.
Ask an Expert